Management of Chronic Pruritus with Fexofenadine

Introduction to Fexofenadine Therapy

The British Association of Dermatologists recommends considering nonsedative antihistamines such as fexofenadine 180 mg or loratadine 10 mg as systemic treatment options for generalized pruritus of unknown origin, though the strength of recommendation is weak (Level D) 1, 2, 3
Fexofenadine 180 mg daily is a reasonable option for chronic pruritus of unknown origin, but its effectiveness is limited and should be considered as part of a broader treatment strategy rather than a first-line monotherapy 1, 2

Start with emollients and self-care advice as the foundation of treatment before adding systemic agents 1, 2
Fexofenadine can be used alone or in combination with H2 antagonists (e.g., fexofenadine plus cimetidine) for potentially enhanced effect 1, 2
The evidence supporting antihistamines for non-histamine-mediated pruritus is limited, as chronic pruritus often involves non-histaminergic pathways 1, 2

Avoid sedating antihistamines for chronic pruritus except in short-term or palliative settings, as long-term use may predispose to dementia 1, 2, 4
Fexofenadine is nonsedating, making it safer for long-term use than first-generation antihistamines 1, 2
For specific causes of chronic pruritus (uraemic, hepatic, neuropathic), antihistamines are generally ineffective and other targeted therapies should be used 1, 4

If fexofenadine is ineffective, consider paroxetine, fluvoxamine, mirtazapine, naltrexone, gabapentin, pregabalin, ondansetron, or aprepitant as second-line systemic agents 1, 2, 3
Phototherapy (NB-UVB) is highly effective for many types of chronic pruritus and should be considered before multiple systemic agents 3
Topical options include doxepin (limited to 8 days, 10% body surface area), clobetasone butyrate, or menthol 1, 2, 3

The British Association of Dermatologists recommends starting with emollients, non-sedating antihistamines (fexofenadina 180 mg or loratadina 10 mg), or topical agents like doxepina topical (limited to 8 days) for generalized pruritus of unknown origin 5
For opioid-induced pruritus, naltrexona is the treatment of choice 5

Identify the type of pruritus (dermatological, systemic, neuropathic, psychogenic, drug-induced) 5
Start with general measures: emollients and self-care 5
First-line systemic treatment: non-sedating antihistamines (fexofenadina 180 mg) 5

The British Association of Dermatologists guidelines suggest that gabapentina or other alternatives should be considered before amitriptilina due to its side effect profile 5

Combine antihistamine therapy with basic skin‑care (e.g., keep nails short and maintain skin hydration with emollients) to enhance pruritus control and reduce scratching‑related skin damage. 6

Refer patients to psychiatry for optimization of mood‑stabilizer regimens and direct management of hypomanic symptoms that may interfere with pruritus treatment. 6
Offer referral to clinical psychology for behavioral interventions such as habit‑reversal training, cognitive restructuring, and relaxation techniques, which can alleviate chronic pruritus without adding pharmacologic interactions. 6

Up to one‑third of individuals with chronic pruritus experience significant anxiety or depression, underscoring the need for integrated psychiatric care alongside dermatologic therapy. 6

Do not assume pruritus is purely psychogenic in patients with psychiatric disorders; systematically evaluate for dermatologic, systemic (renal, hepatic, thyroid), and medication‑induced causes. 6